Abstract
Readers of papers describing the design, methods, or results of randomized controlled trials should exercise critical caution in interpreting what the authors have written. Readers should pay particular attention to important aspects of the design, including the scientific rationale of the study, the choice of control group, the selection of the primary and secondary outcomes, and the planned length of follow-up. In reviewing a paper describing the results of a trial, the reader should ensure that the paper describes the degree of fidelity to the protocol, the amount of missing data along with the methods used to deal with any missing data, the methods of statistical analysis used, and the approaches taken to validate the measurements, the data, and the statistical methods.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Age of Autism: daily web newspaper of the autism epidemic. https://www.ageofautism.com/. Accessed 20 Jan 2019
Boseley S (2010) Lancet retracts ‘utterly false’ MMR paper. The Guardian. https://www.theguardian.com/society/2010/feb/02/lancet-retracts-mmr-paper. Accessed 20 Jan 2019
Caldwell M, Martinez M, Foster JC et al (2019) Prospects for the primary prevention of myocardial infarction and stroke. J Cardiovasc Pharmacol Ther 24:207–214
Colton T (1974) Statistics in medicine. Little Brown and Company, Boston
Cowan C, Wittes J (1994) Intercept studies, clinical trials, and cluster experiments: to whom can we extrapolate? Control Clin Trials 15:24–29
Fisher RA (1936) Annals Sci.1.115. Reprinted in: Stern C, Sherwood ER (eds) (1966) The origin of genetics; a Mendel source book. W.H. Freeman, San Francisco/London
Genentech (2018) Lucentis prescribing information. https://www.gene.com/download/pdf/lucentis_prescribing.pdf. Accessed 26 Jan 2019
Holz FG, Tadayoni R, Beatty S et al (2015) Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration. Br J Opthalmol 99:220–226
Kolata G (2018) Harvard calls for retraction of dozens of studies by noted cardiac researcher. New York Times. https://www.nytimes.com/2018/10/15/health/piero-anversa-fraud-retractions.html. Accessed 20 Jan 2019
ONTARGET Investigators (2008) Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358:1547–1559
Pfeffer MA, Clagget B, Assman SF et al (2014) Regional variation in patients and outcomes in the treatment of preserved cardiac function heart failure with an aldosterone antagonist (TOPCAT) Trial. Circulation 131:34–42
Pitt B, Pfeffer MA, Assman SF et al (2014) Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 370:1383–1392
Proschan M, McMahon R, Shih J et al (2001) Sensitivity analysis using an imputation method for missing binary data in clinical trials. J Stat Plan Inference 96:155–165
Resnick B, Belluz J (2018) A top Cornell food researcher has had 15 studies retracted. Vox. That’s a lot. https://www.vox.com/science-and-health/2018/9/19/17879102/brian-wansink-cornell-food-brand-lab-retractions-jama. Accessed 20 Jan 2019
Ridker PM, Danielson E, Fonseca FAH et al for the JUPITER Study Group (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359:2195–2207
Stony Brook University. http://www.library.stonybrook.edu/scholarly-communication/know-journal-legitimate/. Accessed 31 Jan 2019
Think. Check submit. https://thinkchecksubmit.org. Accessed 26 Jan 2019
Wakefield AJ (1999) MMR vaccination and autism. Lancet 354:949–950
Writing Group for the Women’s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288:321–333
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this entry
Cite this entry
Wittes, J. (2022). Reading and Interpreting the Literature on Randomized Controlled Trials. In: Piantadosi, S., Meinert, C.L. (eds) Principles and Practice of Clinical Trials. Springer, Cham. https://doi.org/10.1007/978-3-319-52636-2_195
Download citation
DOI: https://doi.org/10.1007/978-3-319-52636-2_195
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52635-5
Online ISBN: 978-3-319-52636-2
eBook Packages: Mathematics and StatisticsReference Module Computer Science and Engineering